Interesting post Sicilly.
Seems to me (although I am sure they do not realise it), that American Biomedica is listing the capacities of one of their main competitors (Oraline) than they are their own saliva-based device (OralStat).
Once the 6 and 8 drug versions of Oraline come out, it will meet each and everyone of those criteria at the highest levels - including market leader status with respect to criteria 2-6.
Add to My Watchlist
What is My Watchlist?